Key takeaway
This scoping review found that transient symptoms such as keto-flu, nausea, vomiting and reduced appetite recur across populations when people start a ketogenic diet, but the literature is highly heterogeneous and gives no pooled rates. Few mechanisms or relief strategies, including avoiding a fasted start and adding MCT or ketone salts, have been tested directly.
Study design
Evidence review
Reading basis
Published abstract
Reading focus
Design & applicability
The research question
Ketogenic diets are being used for more clinical purposes, but unpleasant early symptoms, often called keto-flu, may make people quit. The authors reviewed what is known about how often symptoms occur during keto-induction, why they occur, and which strategies are proposed to relieve them.
Who and how
Scoping review. Embase, Medline and Web of Science were searched using terms for ketogenic diets and keto-induction combined with terms for adverse effects, and further studies were taken from reference lists. A scoping review maps the evidence without pooling results or rating study quality. The abstract does not give the number of studies reviewed.
What it found
The authors’ reported results. Read each estimate with its population and uncertainty.
- 1The literature is highly heterogeneous, yet transient symptoms were reported across multiple populations: keto-flu, nausea, emesis, reduced appetite, hypoglycaemia, acidosis, increased risk of kidney stones, altered liver biochemistry and skin rash.
- 2Proposed mechanisms rest on general physiology, and few have been tested empirically.
- 3Reported ways to reduce symptoms include avoiding the traditionally used fasted initiation and supplementing medium-chain triglycerides (MCT) and ketone salts.
- 4Electrolyte and ketone ester supplementation have a physiological rationale, but clinical studies documenting their effect are lacking.
Limits & uncertainty
- 1The abstract gives no occurrence rates, so how common each symptom is remains unknown.
- 2Studies were highly heterogeneous in populations and methods, which makes comparison difficult.
- 3Few studies directly examined symptoms, mechanisms or relief strategies, so the suggestions are largely untested.
- 4Several listed items, such as acidosis, kidney stones and liver changes, are medical findings that go beyond mild keto-flu and the abstract does not say how often they occurred.
What to take from it
If you try a ketogenic diet, expect that some people have a rough first stretch, and the options mentioned in the literature (not starting fasted, MCT, ketone salts) are not proven to work. People with diabetes, kidney, liver or other conditions, or taking medicines for glucose or blood pressure, should speak to their clinician before starting.
Reading your own data
Food logs show how much carbohydrate you are actually eating, and a symptom diary can note energy, nausea and sleep in the first days. A wearable's resting heart rate and sleep could show a rough week, but they cannot tell keto-flu from other causes. Keep a log with dates so changes are easy to review.
How to read this evidence
Check which designs were included, how searches and bias assessment were conducted, and the last search date. Publication date alone does not make the underlying evidence current.
Authors’ structured abstract English
The attributed English abstract is reproduced under the recorded open licence. It is source material, not a MoveVitals interpretation. The prepared analysis above separates the authors’ findings from our interpretation.
Background
Evidence for the clinical utility of ketogenic diets (KD) is mounting. The transition to a KD (keto-induction) can however trigger unpleasant transient symptoms (≪keto-flu≫) which may deter continued adherence. Knowledge of strategies that mitigate symptoms during keto-induction may facilitate adoption of a KD.
Aim
We aimed to perform a scoping review of the available scientific literature with regards to symptom occurrence rates, possible mechanisms and proposed interventions for symptom relief during keto-induction.
Methods
Embase, Medline and Web of Science electronic databases were searched systematically using terms associated with the KD and keto-induction in conjunction with terms capturing adverse effects. In addition, additional relevant studies were retrieved from the identified articles' references.
Results
The available literature on keto-induction symptoms is highly heterogenous, but common transient symptoms are reported across multiple populations, including descriptions of "keto-flu," nausea, emesis, reduced appetite, hypoglycaemia, acidosis, increased risk of kidney stones, altered liver biochemistry, and skin rash. Mechanisms have been proposed based on general insights into physiology, but few have been empirically tested. However, approaches to reduce symptoms of keto-initiation are reported, including avoidance of the traditionally used fasted initiation and supplementation of medium-chain triglycerides (MCT) and ketone salts. There is a physiological rationale for supplementation with electrolytes and ketone esters, but a lack of clinical studies documenting their effect.
Conclusion
Several transient symptoms have been associated with keto-induction, although a limited number of studies have directly examined them, or the mechanisms and possible interventions for symptom alleviation. Further research is warranted to close knowledge gaps highlighted in this review.
Sources & attribution
Symptoms during initiation of a ketogenic diet: a scoping review of occurrence rates, mechanisms and relief strategies.
Skartun O, Smith CR, Laupsa-Borge J, Dankel SN.
Frontiers in nutrition · 2025-03-26
DOI: 10.3389/fnut.2025.1538266 ↗PubMed · 40206956 ↗Europe PMC · Recorded licence: cc by ↗Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.
MoveVitals editorial interpretation · educational content · no individual clinical review recorded
Sources checked 2026-11-01
Practical guides
Read in context
Early time-restricted eating linked to more weight loss and lower insulin than late eating
Pooling 41 randomised trials (2287 participants, median intervention 8 weeks), time-restricted eating was associated with 2.15 kg lower body weight than usual diets (95% CI -2.56 to -1.74), and eating early beat eating late by 1.15 kg (95% CI -1.86 to -0.45). Most trials were short, only 6 study arms tested early eating, and the outcomes were body and blood measures, not heart attacks or deaths.
BMJ Medicine
An 8 a.m. to 4 p.m. eating window added to calorie cutting gave no clear extra weight loss
Among 139 patients with obesity on a calorie-restricted diet, adding an eating window of 8:00 a.m. to 4:00 p.m. led to a mean 12-month weight change of -8.0 kg, versus -6.3 kg with calorie restriction alone. The net difference of -1.8 kg (95% CI -4.0 to 0.4; P = 0.11) was not statistically significant, and the interval cannot rule out either a real benefit or none.
The New England Journal of Medicine
In a 20-person ward trial, an ultra-processed menu led to more eating and weight gain
In 20 adults living in a hospital research unit for 28 days, an ultra-processed menu led them to eat 508 kcal/day more (± 106 SE, P = 0.0001) and gain 0.9 kg, while a menu of unprocessed foods led to a 0.9 kg loss, each over 2 weeks and with eating left to appetite. The study was small, short and fully provisioned, so it cannot show what happens in daily life or which feature of the foods drove the extra eating.
Cell Metabolism
Mediterranean diet with olive oil or nuts linked to fewer heart events (corrected trial)
Among 7447 Spanish adults aged 55 to 80 at high cardiovascular risk, those assigned to a Mediterranean diet with extra-virgin olive oil (HR 0.69, 95% CI 0.53 to 0.91) or with nuts (HR 0.72, 0.54 to 0.95) had fewer major cardiovascular events than those told to cut dietary fat. The trial had randomisation errors, which is why the 2013 report was withdrawn and the estimates recalculated, so treat this as strong but imperfect evidence.
The New England Journal of Medicine

